PCRX - PACIRA INC
Form 10-Q Period: SEP.30.12 Date Filed: NOV.01.12
Transcript Split
  
  
     
Move to First Section Move to Last Section
INDEX
Page-by-Page
  Form 10-Q (Entire Filing)

Filing Body

Page 1: UNITED STATES

Page 2: PACIRA PHARMACEUTICALS, INC.

Page 3: PART I. FINANCIAL INFORMATION

Page 4: PACIRA PHARMACEUTICALS, INC.

Page 5: PACIRA PHARMACEUTICALS, INC.

Page 6: PACIRA PHARMACEUTICALS, INC.

Page 7: PACIRA PHARMACEUTICALS, INC.

Page 8: PACIRA PHARMACEUTICALS, INC.

Page 9: Prompt pay reserve

Page 10: Note 3 FINANCIAL INSTRUMENTS

Page 11: Credit Risk

Page 12: Note 6 GOODWILL AND INTANGIBLE ASSETS

Page 13: Note 7 DEBT AND FINANCING OBLIGATIONS

Page 14: Subsequent Events

Page 15: Stock Incentive Plans

Page 16: Note 10 RELATED PARTY TRANSACTIONS

Page 17: Item 2. MANAGEMENT S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Page 18: Results of Operations

Page 19: Cost of Revenues

Page 20: Selling, General and Administrative Expense

Page 21: Liquidity and Capital Resources

Page 22: Investing Activities

Page 23: Off-Balance Sheet Arrangements

Page 24: Prompt pay reserve

Page 25: Item 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Page 26: PART II OTHER INFORMATION

Page 27: The design, development, manufacture, supply, and distribution of EXPAREL and DepoCyt(e) is highly r

Page 28: If we fail to comply with federal and state healthcare laws, including fraud and abuse and health in

Page 29: We are subject to new legislation, regulatory proposals and healthcare payer initiatives that may in

Page 30: We have incurred significant losses since our inception and anticipate that we will incur continued

Page 31: Our principal stockholders and management own a significant percentage of our stock and will be able

Page 32: Item 6. EXHIBITS

Page 33: SIGNATURES

Exhibits

Interactive Data

   CURRENT PAGE
    Download Current Page as a Word Document  Download Current Page as a PDF Document    Download Excel File of Financials